How can we prevent disease relapse in Graves' orbitopathy after immunosuppressive treatment?

Expert Rev Endocrinol Metab. 2022 Jul;17(4):269-274. doi: 10.1080/17446651.2022.2100344. Epub 2022 Jul 13.
No abstract available

Keywords: Disease relapses; Glucocorticoids; Graves’ orbitopathy; Radioiodine; Rehabilitative Surgery; monoclonal antibodies.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Glucocorticoids
  • Graves Ophthalmopathy* / drug therapy
  • Humans
  • Iodine Radioisotopes
  • Recurrence

Substances

  • Glucocorticoids
  • Iodine Radioisotopes